Global Gastric Stimulation System Market Growth (Status and Outlook) 2025-2031
Description
The global Gastric Stimulation System market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
A Gastric Stimulation System is a medical device designed to treat certain digestive disorders, such as gastroparesis. It involves the implantation of electrodes or devices in the stomach to stimulate and regulate gastric motility and emptying, helping patients with impaired digestive function.
United States market for Gastric Stimulation System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Gastric Stimulation System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Gastric Stimulation System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Gastric Stimulation System players cover Apollo Endosurgery, GI Dynamics, Abbvie Inc (Allergan), Allurion Technologies, Inc., A.M.I. GmbH, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Gastric Stimulation System Industry Forecast” looks at past sales and reviews total world Gastric Stimulation System sales in 2024, providing a comprehensive analysis by region and market sector of projected Gastric Stimulation System sales for 2025 through 2031. With Gastric Stimulation System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastric Stimulation System industry.
This Insight Report provides a comprehensive analysis of the global Gastric Stimulation System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gastric Stimulation System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastric Stimulation System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastric Stimulation System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastric Stimulation System.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastric Stimulation System market by product type, application, key players and key regions and countries.
Segmentation by Type:
Gastric Pacing
Electrical Stimulation
Segmentation by Application:
Hospitals
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Apollo Endosurgery
GI Dynamics
Abbvie Inc (Allergan)
Allurion Technologies, Inc.
A.M.I. GmbH
ReShape Lifesciences Inc
Medtronic
Enterra Medical, Inc.
Please note: The report will take approximately 2 business days to prepare and deliver.
A Gastric Stimulation System is a medical device designed to treat certain digestive disorders, such as gastroparesis. It involves the implantation of electrodes or devices in the stomach to stimulate and regulate gastric motility and emptying, helping patients with impaired digestive function.
United States market for Gastric Stimulation System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Gastric Stimulation System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Gastric Stimulation System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Gastric Stimulation System players cover Apollo Endosurgery, GI Dynamics, Abbvie Inc (Allergan), Allurion Technologies, Inc., A.M.I. GmbH, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Gastric Stimulation System Industry Forecast” looks at past sales and reviews total world Gastric Stimulation System sales in 2024, providing a comprehensive analysis by region and market sector of projected Gastric Stimulation System sales for 2025 through 2031. With Gastric Stimulation System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastric Stimulation System industry.
This Insight Report provides a comprehensive analysis of the global Gastric Stimulation System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gastric Stimulation System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastric Stimulation System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastric Stimulation System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastric Stimulation System.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastric Stimulation System market by product type, application, key players and key regions and countries.
Segmentation by Type:
Gastric Pacing
Electrical Stimulation
Segmentation by Application:
Hospitals
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Apollo Endosurgery
GI Dynamics
Abbvie Inc (Allergan)
Allurion Technologies, Inc.
A.M.I. GmbH
ReShape Lifesciences Inc
Medtronic
Enterra Medical, Inc.
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
88 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Gastric Stimulation System Market Size by Player
- 4 Gastric Stimulation System by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Gastric Stimulation System Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
